+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Colon Cancer Drugs Market Research Reports

Anal Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Anal Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 164 Pages
  • Global
From
Colorectal cancer Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Colorectal cancer Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Regorafenib Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Regorafenib Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
AVASTIN Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

AVASTIN Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Metastatic Colorectal Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Metastatic Colorectal Cancer - Epidemiology Forecast - 2032

  • Drug Pipelines
  • February 2022
  • 154 Pages
  • Global
From
Metastatic Colorectal Cancer - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Metastatic Colorectal Cancer - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • February 2022
  • 308 Pages
  • Global
From
Bevacizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Bevacizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Familial Adenomatous Polyposis - Epidemiology forecast- 2032 - Product Thumbnail Image

Familial Adenomatous Polyposis - Epidemiology forecast- 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Anal Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Anal Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Colorectal Cancer (CRC) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Colorectal Cancer (CRC) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Anus Neoplasms - Epidemiology Forecast to 2032 - Product Thumbnail Image

Anus Neoplasms - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Colorectal Neoplasm - Epidemiology Forecast to 2032 - Product Thumbnail Image

Colorectal Neoplasm - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Microsatellite Stable Colorectal Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Microsatellite Stable Colorectal Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
In-vitro Colorectal Cancer Screening Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

In-vitro Colorectal Cancer Screening Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • April 2024
  • 180 Pages
  • Global
From
Colorectal Cancer Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Colorectal Cancer Therapeutics Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Colorectal Cancer Therapeutics Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Colorectal Cancer Therapeutics Market Analysis & Forecast to 2024-2034

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Braftovi (encorafenib) + Erbitux (cetuximab) + Mektovi (binimetinib) Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Braftovi (encorafenib) + Erbitux (cetuximab) + Mektovi (binimetinib) Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Middle East & Africa Colorectal Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality [Imaging Tests and Stool-Based Tests] and End User - Product Thumbnail Image

Middle East & Africa Colorectal Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality [Imaging Tests and Stool-Based Tests] and End User

  • Report
  • August 2023
  • 131 Pages
  • Middle East, Africa
From
Europe Colorectal Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality [Imaging Tests and Stool-Based Tests] and End User - Product Thumbnail Image

Europe Colorectal Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality [Imaging Tests and Stool-Based Tests] and End User

  • Report
  • August 2023
  • 158 Pages
  • Europe
From
Loading Indicator

The Colon Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat colon cancer. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy drugs are used to kill cancer cells and stop them from growing. Targeted therapy drugs are designed to target specific cancer cells and block their growth. Immunotherapy drugs are used to boost the body’s natural immune system to fight cancer cells. Some of the major companies in the Colon Cancer Drugs market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Eli Lilly. These companies are involved in the research, development, and marketing of drugs used to treat colon cancer. Show Less Read more